**Core Concept**
Gene therapy is a medical intervention that aims to modify or replace a faulty gene responsible for a genetic disorder. In pediatrics, gene therapy has been explored as a potential treatment for several diseases, particularly those caused by single-gene defects.

**Why the Correct Answer is Right**
Severe Combined Immunodeficiency (SCID) is a group of rare genetic disorders characterized by the absence or near-absence of functional T and B lymphocytes, leading to severe impairment of the immune system. Gene therapy targeting SCID involves correcting the underlying genetic defect responsible for the disease, typically by introducing a healthy copy of the defective gene into the patient's hematopoietic stem cells. This approach has shown promising results in clinical trials, with some patients achieving complete immune reconstitution.

**Why Each Wrong Option is Incorrect**
**Option B:** Cancer is a complex and multifactorial disease, and while gene therapy has been explored as a potential treatment, it is not the most common target for gene therapy in pediatrics. Cancer gene therapy typically involves strategies such as tumor suppressor gene therapy, immunotherapy, or suicide gene therapy, which are more nuanced than correcting a single-gene defect.
**Option C:** Cystic fibrosis is a genetic disorder caused by mutations in the CFTR gene, but gene therapy for this condition is more challenging due to the complex nature of the disease and the need to correct multiple mutations. While gene therapy has been explored for cystic fibrosis, it is not as advanced as gene therapy for SCID.
**Option D:** Leukemia is a type of cancer that affects the blood and bone marrow, and while gene therapy has been explored as a potential treatment, it is not the most common target for gene therapy in pediatrics. Gene therapy for leukemia typically involves strategies such as immunotherapy or targeted gene therapy, which are more complex than correcting a single-gene defect.

**Clinical Pearl / High-Yield Fact**
Gene therapy for SCID often involves retroviral vectors to introduce the healthy gene into hematopoietic stem cells, which can then produce healthy immune cells. This approach has shown significant promise in clinical trials, with some patients achieving complete immune reconstitution and a reduced risk of infections.

**✓ Correct Answer: A. SCID**